title: 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary.
abstract: BACKGROUND
  Recent neurophysiological evidence attests to the validity of fibromyalgia (FM), a chronic pain condition that affects >2% of the population.
  
  
  OBJECTIVE
  To present the evidence-based guidelines for the diagnosis, management and patient trajectory of individuals with FM.
  
  
  METHODS
  A needs assessment following consultation with diverse health care professionals identified questions pertinent to various aspects of FM. A literature search identified the evidence available to address these questions; evidence was graded according to the standards of the Oxford Centre for Evidence-Based Medicine. Drafted recommendations were appraised by an advisory panel to reflect meaningful clinical practice.
  
  
  RESULTS
  The present recommendations incorporate the new clinical concepts of FM as a clinical construct without any defining physical abnormality or biological marker, characterized by fluctuating, diffuse body pain and the frequent symptoms of sleep disturbance, fatigue, mood and cognitive changes. In the absence of a defining cause or cure, treatment objectives should be patient-tailored and symptom-based, aimed at reducing global complaints and enhancing function. Healthy lifestyle practices with active patient participation in health care forms the cornerstone of care. Multimodal management may include nonpharmacological and pharmacological strategies, although it must be acknowledged that pharmacological treatments provide only modest benefit. Maintenance of function and retention in the workforce is encouraged.
  
  
  CONCLUSIONS
  The new Canadian guidelines for the treatment of FM should provide health professionals with confidence in the complete care of these patients and improve clinical outcomes.
authors.affiliation: Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada. mary-ann.fitzcharles@muhc.mcgill.ca
authors.forename: Mary-Ann
authors.initials: MA
authors.lastname: Fitzcharles
authors.forename: Peter A
authors.initials: PA
authors.lastname: Ste-Marie
authors.forename: Don L
authors.initials: DL
authors.lastname: Goldenberg
authors.forename: John X
authors.initials: JX
authors.lastname: Pereira
authors.forename: Susan
authors.initials: S
authors.lastname: Abbey
authors.forename: Manon
authors.initials: M
authors.lastname: Choinière
authors.forename: Gordon
authors.initials: G
authors.lastname: Ko
authors.forename: Dwight E
authors.initials: DE
authors.lastname: Moulin
authors.forename: Pantelis
authors.initials: P
authors.lastname: Panopalis
authors.forename: Johanne
authors.initials: J
authors.lastname: Proulx
authors.forename: Yoram
authors.initials: Y
authors.lastname: Shir
mesh_terms: D002170:Canada; D019317:Evidence-Based Medicine / Q000331:legislation & jurisprudence; D005356:Fibromyalgia / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D010146:Pain / Q000175:diagnosis / Q000188:drug therapy; D010808:Physical Examination